View of Intravesical Administration of Radiolabelled Tumour-associated Monoclonal Antibody in Bladder CancerConsiderable progress has been made over the past decade in the use of tumour-associated monoclonal antibodies (mAbs) as carriers of cytotoxic agents in th

Return to Article Details Intravesical Administration of Radiolabelled Tumour-associated Monoclonal Antibody in Bladder CancerConsiderable progress has been made over the past decade in the use of tumour-associated monoclonal antibodies (mAbs) as carriers of cytotoxic agents in th Download Download PDF